The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Clearside Biomedical, Inc(NASDAQ:CLSD) 
Clearside Biomedical, Inc., a biopharmaceutical company, engages in the developing and delivering treatments that restore and preserve vision for people with serious eye diseases. Its product includes CLS-AX, an axitinib for suprachoroidal injection which is in Phase 1/2a clinical trial. It also dev...
Website: http://www.clearsidebio.com
Founded: 2011
Full Time Employees: 33
Sector: Healthcare
Industry: Biotechnology
Clearside Biomedical Days Payable Outstanding ttm (DPO)
Clearside Biomedical Days Receivable Outstanding ttm (DSO)
Clearside Biomedical Days Inventory Outstanding ttm (DIO)
Clearside Biomedical Op Cashflow Per Share ttm
Clearside Biomedical Free Cashflow Per Share ttm
Clearside Biomedical Cash Per Share ttm
Clearside Biomedical P/S ratio ttm
Clearside Biomedical (GAAP) P/E ratio ttm
Clearside Biomedical P/B ratio ttm
No extra charts and metrics for this ticker.